bw 501c has been researched along with methysergide in 1 studies
| Studies (bw 501c) | Trials (bw 501c) | Recent Studies (post-2010) (bw 501c) | Studies (methysergide) | Trials (methysergide) | Recent Studies (post-2010) (methysergide) |
|---|---|---|---|---|---|
| 17 | 0 | 0 | 2,935 | 81 | 80 |
| Protein | Taxonomy | bw 501c (IC50) | methysergide (IC50) |
|---|---|---|---|
| 5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 0.0021 | |
| Alpha-2A adrenergic receptor | Homo sapiens (human) | 1.631 | |
| D(2) dopamine receptor | Homo sapiens (human) | 0.807 | |
| Alpha-2B adrenergic receptor | Homo sapiens (human) | 4.763 | |
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 0.054 | |
| D(1A) dopamine receptor | Homo sapiens (human) | 0.943 | |
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 0.013 | |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 0.0021 | |
| 5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 0.054 | |
| D(3) dopamine receptor | Homo sapiens (human) | 0.172 | |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.0006 | |
| 5-hydroxytryptamine receptor 6 | Homo sapiens (human) | 0.162 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ellam, LD; Harrison, MJ | 1 |
1 other study(ies) available for bw 501c and methysergide
| Article | Year |
|---|---|
Role of 5HT in the morbidity of cerebral infarction-a study in the gerbil stroke model.
Topics: 5-Hydroxytryptophan; Amidines; Animals; Brain Chemistry; Cerebral Infarction; Cyproheptadine; Fenclonine; Gerbillinae; Metergoline; Methysergide; Pargyline; Quipazine; Serotonin; Serotonin Antagonists | 1981 |